Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Operating Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Operating Profit (Excl OI) ₹1,269 Cr₹1,333 Cr₹1,025 Cr₹1,510 Cr₹1,302 Cr

What is the latest Operating Profit of GLAND PHARMA ?

The latest Operating Profit ratio of GLAND PHARMA is ₹1,269 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹1,269 Cr
Mar2025₹1,333 Cr
Mar2024₹1,025 Cr
Mar2023₹1,510 Cr
Mar2022₹1,302 Cr

How is Operating Profit of GLAND PHARMA Trending?

Years Operating Profit % Change
Mar2026 ₹1,269 Cr
-4.81
Mar2025 ₹1,333 Cr
30.09
Mar2024 ₹1,025 Cr
-32.14
Mar2023 ₹1,510 Cr
15.97
Mar2022 ₹1,302 Cr -

Compare Operating Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,619.8 Cr 3% 14.8% 46.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3%

14.8%

46.7%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses